MCRB

Seres Therapeutics, Inc. - Common Stock (MCRB)

About Seres Therapeutics, Inc. - Common Stock (MCRB)

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Details

Daily high

$7.54

Daily low

$7.25

Price at open

$7.46

52 Week High

$30.60

52 Week Low

$6.53

Market cap

65.5M

Dividend yield

0.00%

Volume

93,613

Avg. volume

72,283

P/E ratio

-.75

Seres Therapeutics, Inc. - Common Stock News